Clinical Utility of Nanopore-Based Targeted and Metagenomic Sequencing for Rapid Diagnosis of Infections
Year: 2026
Type: article
Abstract: Background Rapid diagnosis is critical for acute invasive infections, yet conventional culture is time-consuming. The real-time, long-read capability of nanopore sequencing facilitates rapid diagnosis, but standardized workflows are lacking. Here, we describe 2 nanopore sequencing workflows, nanopore targeted sequencing (NTS) and nanopore metagenomic sequencing (NMgS), for pathogen and antimicrobial resistance identification. Methods A total of 176 residual clinical specimens, of which >90% were abdominal, pleural, joint, abscess, and bile samples, were analyzed using the NTS and NMgS workflows and compared with culture. NTS employed multiplex PCR to amplify 16S rRNA gene, internal transcribed spacer region, and 30 resistance genes, while NMgS involved host DNA depletion and unbiased sequencing. Results Among 152 culture-positive samples, NTS achieved 98.68% positivity, compared with 69.08% for NMgS. NTS identified 79.93% of cultured species, while NMgS detected 44.89%. For 24 culture-negative samples, NTS identified potential pathogens in 6 cases, whereas NMgS detected none. For antimicrobial resistance detection, NTS achieved a sensitivity of 84.62% for β-lactam resistance, 62.50% for quinolones, and 31.25% for aminoglycosides, with corresponding specificities of 87.10%, 75.86%, and 96.61%. Conversely, NMgS showed lower sensitivities of 36.84%, 16.67%, and 12.50% for these classes, while maintaining 100% specificity across all categories. Using the 4-h sequencing workflow, NTS and NMgS achieved comparable sample-to-report times (10.83 vs 10.41 h). Conclusion This study demonstrates the potential of nanopore sequencing for rapid diagnosis and provides practical insights for its implementation in clinical laboratories. While NTS is sensitive and cost-effective, NMgS offers a hypothesis-free approach. These workflows may complement routine culture in specific clinical contexts.
Source: Clinical Chemistry
Authors: Hiu-Yin Lao, Tin-Nok Hung, Timothy Ting-Leung Ng, Wing-Yin Tam, Tsun-Ming Lok, Alison Yee-Ting Lam, Kam-Tong Yip, Chi-Ka Cheng, Miranda Chong-Yee Yau, Alex Yat-Man Ho, River Chun-Wai Wong, Tak-Lun Que, Kitty Sau-Chun Fung, Sandy Ka-Yee Chau, Jimmy Yiu-Wing Lam, Kristine Shik Luk, Kin-Ping Lee, Viola Chi-Ying Chow, Gilman Kit-Hang Siu
Language: English
Subfield: Microbiology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,636
Funder: Health and Medical Research Fund
OpenAlex ID: W7236836017
